VEGFB and non-small cell lung carcinoma: More specifically, VEGF-B and sPD-1 levels were both found to be significantly decreased in NSCLC patients as compared to healthy sex- and age-matched controls and to be able to discriminate between patients and controls with an optimal cut-off of 10.94 pg/mL and 34.54 pg/mL, respectively.